Van Houte Hans

EDGAR CIK 0001817217

Nurix Therapeutics, Inc. - NRIX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
3
($428,240)
-25,100 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/04/2026
10b5-1
08/04/2026
Sell
-4,761 @ $24.36
 ($115,989) 40,166 (-10.60%) Direct
05/05/2026
10b5-1
05/05/2026
Sell
-14,055 @ $16.60
 ($233,319) 37,592 (-27.21%) Direct
11/03/2025
10b5-1
11/03/2025
Sell
-6,284 @ $12.56
 ($78,931) 37,592 (-14.32%) Direct